The released HG will in turn down‐regulate SIK2 activity and consequently inhibit its downstream proteins (e.g., mTOR, DRP1, and ACC1) to efficiently suppress ovarian cancer proliferation and metastasis (Scheme 1b). The gene discussed is SIK2; the disease is ovarian carcinoma.